A practical look at the CJC-1295 no DAC ipamorelin protocol, including blend ratios, typical research dosages, timing, and safety considerations.
The CJC-1295 no DAC ipamorelin protocol most often discussed in research and community settings combines equal weights of both peptides in a single vial and delivers one small subcutaneous injection, usually before bed on an empty stomach. A 5 mg / 5 mg blend is the most common ratio, and a 10 mg / 10 mg vial follows the same logic at double the concentration. Neither peptide is FDA-approved for human use in the United States, so everything below describes research practices and self-reported experiences rather than medical guidance.
What CJC-1295 No DAC and Ipamorelin Actually Do
CJC-1295 without DAC, also written as MOD GRF 1-29, is a growth hormone-releasing hormone (GHRH) analog. It signals the pituitary to release growth hormone, but its short half-life means that signal is brief. Ipamorelin is a ghrelin receptor agonist that triggers a separate pathway for GH release.
Because the two act on different receptors, they are usually stacked rather than compared head to head. Pairing them is thought to produce a broader GH pulse than either one alone.
- CJC-1295 no DAC: roughly a 30-minute half-life; mimics a natural GHRH pulse.
- Ipamorelin: half-life around two hours; generally described as more selective than GHRP-6 or GHRP-2.
Ipamorelin is generally described in the research literature as more selective than older ghrelin mimetics, meaning it appears to produce less cortisol and prolactin stimulation at typical research doses.
Blend Ratios: 5 mg / 5 mg, 10 mg / 10 mg, and What They Mean
A cjc 1295 no dac and ipamorelin blend is normally sold as a lyophilized powder with both peptides in one vial. The ratio tells you how much of each peptide is in the vial, not how strong a single injection will be.
| Blend Label | Total Peptide per Vial | Common Reconstitution Volume | Resulting Concentration |
|---|---|---|---|
| 5 mg / 5 mg | 10 mg | 2 mL bacteriostatic water | 2.5 mg of each per mL |
| 5 mg / 5 mg | 10 mg | 5 mL bacteriostatic water | 1 mg of each per mL |
| 10 mg / 10 mg | 20 mg | 4 mL bacteriostatic water | 2.5 mg of each per mL |
| 2 mg / 2 mg | 4 mg | 2 mL bacteriostatic water | 1 mg of each per mL |
Reconstitution volume is what sets the concentration. A 5 mg / 5 mg vial mixed with 2 mL of water yields 2.5 mg of each peptide per mL, so a 10-unit (0.1 mL) draw on a U-100 insulin syringe delivers 250 mcg of each. The identical vial mixed with 5 mL yields 1 mg per mL, so the same 10-unit draw delivers 100 mcg of each.
When people look up cjc-1295 no dac ipamorelin 10mg blend dosage, they are usually trying to convert a larger vial into the same per-injection amount. That answer depends entirely on how much water is added, not on the label size.
How to Take CJC-1295 No DAC Ipamorelin: Timing, Frequency, and Cycle Length
Most community protocols follow a similar structure, though none of it comes from controlled human trials. The routine typically looks like this:
- Route: subcutaneous injection into the abdomen or upper thigh.
- Stomach state: at least two hours after the last meal, since food and insulin can blunt a GH pulse.
- Timing: a single dose 30 to 60 minutes before sleep, when natural GH release peaks; some people split it into a fasted morning dose and a pre-bed dose.
- Frequency: once or twice daily.
- Cycle: 8 to 12 weeks on with about 4 weeks off is widely repeated, though longer runs also appear in self-reported logs.
There is no published human trial that defines an optimal schedule for this combination, so any timeline you see online is a convention rather than an evidence-based standard.
CJC-1295 No DAC Ipamorelin 5 5 Dosage: Reading the Common Numbers
A 5 5 label refers to a 5 mg / 5 mg blend. The injection amount people report most often is 100 mcg of each peptide, which on a 2 mL reconstitution equals 10 units on a U-100 insulin syringe.
Twice-daily use at that amount works out to 200 mcg of each peptide per day. Some people go higher, up to roughly 200 mcg of each per injection, but research on ipamorelin suggests GH release plateaus near 1 mcg per kg of body weight, so larger numbers are not automatically better.
General conversation about cjc-1295 no dac dosage follows the same pattern: a short, pulsatile signal is the goal, which is exactly why the no-DAC version is dosed more frequently than CJC-1295 with DAC.
CJC-1295 DAC vs No DAC: Which Is Better for This Stack?
The question of cjc-1295 dac vs no dac which is better comes down to pulse versus plateau. CJC-1295 with DAC binds to albumin and stays active for days, so it can be injected once or twice a week. CJC-1295 without DAC clears in well under an hour, which keeps GH release closer to the body's natural rhythm but requires daily dosing.
Most stacked protocols pair ipamorelin with the no-DAC version because both peptides then rise and fall on a comparable timeline. Comparisons with tesamorelin usually note that tesamorelin holds an FDA approval for a specific medical condition (HIV-associated lipodystrophy), while CJC-1295 no DAC and ipamorelin hold none.
Safety, Side Effects, and Legal Status
Reported side effects from self-experimentation include water retention, puffy hands or face, tingling or numbness in the extremities, headache, increased hunger, and injection-site irritation. Ipamorelin is often called the gentlest ghrelin mimetic in terms of cortisol and prolactin response, but that does not make it risk-free.
CJC-1295 without DAC and ipamorelin are not approved by the FDA for any human use. Vials sold online typically carry a "for research use only" label, and purity varies widely between suppliers, which is a real quality-control concern.
Anecdotal reports on cjc 1295 no dac ipamorelin reddit threads often claim better sleep, faster recovery, and improved skin within a few weeks. Forum reports are not clinical evidence, and they are heavily influenced by expectation, training, diet, and other variables.
Anyone considering these compounds should speak with a licensed healthcare professional first. Long-term human safety data for either peptide is essentially absent, and bloodwork is frequently part of self-monitoring in community logs.
Frequently Asked Questions
How much CJC-1295 no DAC and ipamorelin should I take per day?
Community protocols most commonly describe 100 mcg of each peptide per injection, once or twice daily, which totals 200 to 400 mcg of each per day. Those numbers come from forum discussions rather than controlled human trials. Neither peptide is FDA-approved for human use, so any dosing decision should be discussed with a licensed healthcare professional.
What does 5 5 mean on a CJC-1295 no DAC ipamorelin blend?
A 5 5 label means the vial contains 5 mg of CJC-1295 without DAC and 5 mg of ipamorelin, for 10 mg of total peptide. The amount delivered per injection depends on how much bacteriostatic water you add, not on the ratio itself. A 10 mg / 10 mg vial is simply a larger version of the same 1:1 ratio.
Do you need to cycle CJC-1295 no DAC and ipamorelin?
Most self-reported protocols run 8 to 12 weeks on followed by about 4 weeks off, though some people stay on for several months. No clinical evidence establishes an ideal cycle length for this combination. Because long-term safety data is limited, cycling choices should be reviewed with a healthcare professional.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.